Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review

SIMPLE SUMMARY: Even though up to 20% of patients with cancer eventually develop brain metastases (BM), most clinical trials have historically forbidden the enrolment of individuals with BM. The reasons for this practice include considerations regarding safety and efficacy, but there is a pressing n...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchnowska, Renata, Saad, Everardo D., Banaszek, Małgorzata, Pawłowska, Ewa, Liberek, Hanna, Cichowska-Cwalińska, Natalia, Jassem, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582366/
https://www.ncbi.nlm.nih.gov/pubmed/34771468
http://dx.doi.org/10.3390/cancers13215306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582366/
https://www.ncbi.nlm.nih.gov/pubmed/34771468
http://dx.doi.org/10.3390/cancers13215306

Ejemplares similares